Aditya Sarode
- University of Strathclyde
I am currently pursuing my PhD at the University of Strathclyde, where I am part of the highly regarded Doctoral Training Program. My academic journey began in India, where I earned a Bachelor of Pharmacy from Pune University. This rigorous program provided me with a comprehensive understanding of pharmaceutical sciences, encompassing both theoretical knowledge and practical laboratory skills. As an international student in the UK, I have had the opportunity to immerse myself in a vibrant and diverse academic environment that encourages interdisciplinary collaboration and innovation. The transition from Pune to Strathclyde has been instrumental in shaping my research capabilities, offering me access to state-of-the-art facilities, mentorship from leading experts, and the chance to engage in cutting-edge research that addresses some of the most pressing challenges in the field of pharmaceutical sciences.
My current research project is titled "Design and Development of Novel Agents for the Treatment of Animal Trypanosomiasis," and it lies at the forefront of synthetic chemistry and antimicrobial resistance research. Animal trypanosomiasis, caused by the trypanosoma parasite, is a significant concern in many parts of the world, leading to severe economic losses in livestock and posing a threat to food security. My work focuses on exploring and developing a class of compounds known as Strathclyde Minor Groove Binders, which have shown promising potential as therapeutic agents against trypanosoma infections. By synthesizing and testing these novel compounds, I aim to uncover new mechanisms of action that can effectively target the parasite, offering hope for more efficient and safer treatments. This research not only contributes to the fight against a neglected tropical disease but also addresses the broader issue of antimicrobial resistance, which is an escalating global health threat. Through my work, I aspire to make a meaningful impact in the field of medicinal chemistry and contribute to the development of innovative solutions for combating infectious diseases.